PTH and osteoporosis: The current therapies for osteoporosis, including bisphosphonates, RANKL (receptor activator of nuclear factor kappa beta ligand) inhibitors, estrogen agonists/antagonists, parathyroid hormone (PTH) analogs, calcitonin, cathepsin K inhibitors, and sclerostin monoclonal antibodies, have certain limitations [7].